close

Join our Mailing List

Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.

Tag
Michael Cross
Mar 16, 2016
FACIT invests in new CPDC spin-out company to aid development of potent radiotherapeutic
FACIT invests in new CPDC spin-out company to aid development of potent radiotherapeutic
Looking Ahead
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.
Subscribe